Latebreaker: Skip the Chemo: Landmark Findings about Breast Cancer

Women with early-stage breast cancer may not need any chemotherapy. That’s the treatment-transforming finding from just-published research in The New England Journal of Medicine, which drew on more than 10,000 women for the study. By analyzing the genetics of tumor samples removed during surgery, doctors were able to distinguish between those who might gain additional benefit from chemo, with all of its toxic side effects, and those who could safely skip it. Joined by the CEO of the American Cancer Society, one of the lead authors of the study talks about its conclusions and how they will change standards of care.

Festival: Spotlight Health 2018

Watch and Listen: Health

Larry Smarr believes in being the CEO of his own body, and for years, he has been measuring inputs (food and drink) and... See more
Once associated mostly with IV poles and standard-issue hospital gowns, health-related design has entered a new era... See more
Despite repeated attempts, Congress has not repealed the Affordable Care Act, although the Trump Administration has... See more
The Affordable Care Act became law because five congressional leaders made it happen. These committee chairs — two from... See more
Despite all of the scientific advances in genomic sequencing, genetic testing, and gene editing, science writer Carl... See more
Whether the headlines describe a “cancer moonshot” or a “war on cancer,” they capture a yearning and determination to... See more

Pages